The 20 Best Eccrine Porocarcinoma Doctors Near Me in Michigan, US

Dr. Kelly Harms, MD, PhD, is a faculty member in the Department of Dermatology at the University of Michigan and the director of our Multi-disciplinary Cutaneous Oncology clinic. She provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the U-M Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our Multidisciplinary Melanoma and Merkel Cell Programs.Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, and Basal Cell Skin Cancer. Dr. Harms is board certified in Dermatology and Micrographic Dermatologic Surgery.

Dr. Christopher Bichakjian is professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School.Dr. Bichakjian is a foremost expert in the field of cutaneous surgery and oncology. He has a special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006. He has presented over 100 national and international invited lectures and visiting professorships, and authored or co-authored nearly 90 peer-reviewed publications with a primary focus on cutaneous oncology.Dr. Bichakjian received his medical degree from Radboud University in The Netherlands. After relocating to the US, he completed residency in dermatology and fellowship in micrographic surgery and cutaneous oncology at Michigan Medicine. He subsequently practiced Mohs surgery in private practice and served as adjunct faculty at Weill Medical College at Cornell University in New York City.In 2004, Dr. Bichakjian was recruited back to Ann Arbor to join the faculty in the Department of Dermatology at Michigan Medicine. He served as director of the UM Multidisciplinary Merkel Cell Carcinoma Program for more than a decade (2006-2017), In addition, he served as chief of the Division of Cutaneous Surgery and Oncology and as director of the Multidisciplinary Melanoma Program in the Rogel Cancer Center from 2017-2020. Dr. Bichakjian is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Basal Cell Skin Cancer, Melanoma, and Eccrine Porocarcinoma. Dr. Bichakjian is board certified in Dermatology and Micrographic Dermatologic Surgery.

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.

Scott Mclean is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Mclean is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Teratocarcinosarcoma, Sinus Cancer, Tissue Biopsy, and Laryngectomy. Dr. Mclean is board certified in Otolaryngology-Head & Neck Surgery.

Jeffrey H. Kozlow, MD, serves as a Clinical Associate Professor in the Section of Plastic and Reconstructive Surgery at the University of Michigan School of Medicine. A native of Southeastern Michigan, Dr. Kozlow received his Bachelors of Arts in Psychology and Chemistry from Cornell University. He graduated from Johns Hopkins University School of Medicine for his M.D. degree. He underwent Plastic Surgery Residency training at the University of Michigan followed by an additional one-year fellowship in Microvascular Reconstructive Surgery at the University of Texas – MD Anderson Cancer Center. He has returned to the University of Michigan joining the faculty in 2011. Clinical Specialization: Dr. Kozlow is clinically focused on the reconstruction of oncologic and traumatic defects. His microsurgical training allows him to perform abdominally-based breast reconstruction including DIEP and muscle-sparing TRAM flaps. He partners with members of the University of Michigan Rogel Cancer Center to provide an integrated and multi-disciplinary reconstruction for complex defects including the extremities and pelvis. His goal is to perform reconstructions that optimize the function and form that can be lost following the surgical removal of tumors. He also treats patients with primary cutaneous malignancies including melanoma and other skin cancers. Dr. Kozlow is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Eccrine Porocarcinoma, Melanoma, Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Kozlow is board certified in Plastic Surgery.

Benjamin Gielda is a Radiation Oncologist practicing medicine in Saint Joseph, Michigan. He has been practicing medicine for over 20 years. Dr. Gielda is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, Familial Prostate Cancer, and Gamma Knife Radiosurgery. Dr. Gielda is board certified in American Board Of Radiology. Dr. Gielda is currently accepting new patients.

Peter Paximadis is a Radiation Oncologist practicing medicine in Saint Joseph, Michigan. He has been practicing medicine for over 18 years. Dr. Paximadis is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Prostate Cancer, and Familial Prostate Cancer. Dr. Paximadis is board certified in American Board Of Radiology.

Dr. Elisabeth (Beth) Pedersen is an Assistant Professor in the Department of Dermatology at the University of Michigan. She is a board-certified dermatologist and provides patient care within our Multidisciplinary Cutaneous Oncology Clinic at the Taubman Center and Rogel Cancer Center.Dr. Pedersen specializes in advanced and high-risk skin cancer. She sees patients with Merkel cell carcinoma, melanoma, and advanced basal cell carcinoma. She also has a particular interest in rare skin cancers including dermatofibrosarcoma protuberans and other skin sarcomas.Dr. Pedersen received her Doctor of Medicine (MD) and Doctor of Philosophy (PhD) degrees through at the University of Michigan. She completed dermatology residency and postdoctoral research training at the University of Michigan Medical School. In addition to her clinical practice, she performs laboratory research focused on understanding the molecular and cellular biology of skin cancers, with the goal of identifying new strategies for cancer treatment. Dr. Pedersen is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Eccrine Porocarcinoma, Melanoma, and Sunburn.

Richard Keidan is a General Surgeon practicing medicine in Farmington Hills, Michigan. He has been practicing medicine for over 46 years. Dr. Keidan is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Melanoma, Eccrine Porocarcinoma, Merkel Cell Carcinoma, and Liposarcoma. Dr. Keidan is board certified in American Board Of Surgery. Dr. Keidan is currently accepting new patients.

Gerald Wright is a Surgical Oncologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 16 years. Dr. Wright is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Post-Splenectomy Syndrome, Mastectomy, and Pancreaticoduodenectomy. Dr. Wright is board certified in American Board Of Surgery and American Board Of Surgery.

Dr. Jennifer Schwartz received her medical degree from Northwestern University Medical School and completed her internship in internal medicine at Northwestern Medical Center in Chicago. She completed her dermatology residency at the University of Michigan Department of Dermatology and two years of specialty training in melanoma at the U-M Rogel Cancer Center.Additionally, she completed advanced specialty training in cutaneous surgery treatment of benign and malignant lesions at the University of Michigan. In 1999, Dr. Schwartz became a faculty member of the Melanoma and Cutaneous Oncology and Surgery Program. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Melanoma, Eccrine Porocarcinoma, Squamous Cell Skin Carcinoma, and Merkel Cell Carcinoma. Dr. Schwartz is board certified in Dermatology.

Jill Gadzinski is an Oncologist and a Surgical Oncologist practicing medicine in Royal Oak, Michigan. She has been practicing medicine for over 16 years. Dr. Gadzinski is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy. Dr. Gadzinski is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Gadzinski is currently accepting new patients.

Leigh Seamon is a Surgical Oncologist and an Oncologist practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 26 years. Dr. Seamon is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Splenectomy, and Oophorectomy. Dr. Seamon is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Seamon is currently accepting new patients.

"Dr. Michael J. Davis is a Clinical Assistant Professor and board-certified Mohs surgeon and dermatologist in the Michigan Medicine Department of Dermatology. He provides expert care for patients with high-risk and advanced skin cancer in the Cutaneous Surgery and Oncology outpatient clinic at the UM Rogel Cancer Center and is a member of the multidisciplinary cutaneous oncology program.Dr. Davis graduated from the School of Medicine at Emory University, completed a dermatology residency at Dartmouth University, and pursued a Micrographic Surgery and Dermatologic Oncology clinical fellowship at Scripps Health in La Jolla, California. He completed a one-year Cutaneous Oncology Research Fellowship at Memorial Sloan Kettering Cancer Center, where he also served as an instructor of dermatology and interim assistant director of the Mohs lab for the Dermatology Service.Dr. Davis’s clinical and scholarly interests center on cutaneous surgery and oncology, with an emphasis on Mohs histopathology. He has co-authored seven chapters for the ""Laboratory Manual for Mohs Micrographic Surgery Frozen Tissue Processing,"" a comprehensive reference on the Mohs tissue processing technique (Springer, April 2024). He is an active member of the American Academy of Dermatology, the American Society for Dermatologic Surgery, the American College of Mohs Surgery, and the International Immunosuppression and Transplant Skin Cancer Collaborative.". Dr. Davis is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Davis is board certified in Micrographic Dermatologic Surgery and Dermatology. Dr. Davis is currently accepting new patients.

Dr. Milad Eshaq, Clinical Associate Professor of Dermatology, is a board-certified dermatologist and fellowship-trained Mohs surgeon in the University of Michigan Department of Dermatology. He provides patient care in our Cutaneous Surgery and Oncology outpatient clinic at the Rogel Cancer Center as well as the Domino’s Farms Dermatology Clinic. In addition, Dr. Eshaq provides state-of-the-art cosmetic dermatology procedures and laser treatment within the Cosmetic Dermatology & Laser Center.Dr. Eshaq received his medical degree from the Medical College of Wisconsin in Milwaukee, Wisconsin. He completed his transitional year at Henry Ford Health System in Detroit, Michigan, and his dermatology residency at the University of Michigan, serving as Chief Resident during his final year. Dr. Eshaq joined the dermatology faculty at Michigan Medicine in 2017, serving as Chief of Medical Dermatology and Ambulatory Care Clinical Chief for Dermatology from 2019-2023. He completed a clinical fellowship in Micrographic Surgery & Dermatologic Oncology at Michigan Medicine during 2024 and was appointed as Clinical Associate Professor of Dermatology in 2025. Dr. Eshaq is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Melanoma, Bullous Pemphigoid, Actinic Keratosis, and Hidradenitis Suppurativa. Dr. Eshaq is board certified in Dermatology.

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Scott Regenbogen, MD, MPH is a Professor of Surgery and Division Chief of Colorectal Surgery. He graduated from Princeton University with an A.B. in psychology, and received his M.D. degree from the University of California, San Francisco. He completed General Surgery residency at the Massachusetts General Hospital, including three years as a Postdoctoral Fellow in Health Services Research, and was awarded a Master’s in Public Health from the Harvard School of Public Health. He then completed fellowship training in Colon and Rectal Surgery at the Lahey Clinic, and joined the faculty of the University of Michigan in 2011.Clinical SpecializationDr. Regenbogen's clinical practice includes the evaluation and management of benign and neoplastic diseases of the small bowel, colon, rectum, and anus. He has a particular interest in the use of laparoscopic techniques for the management of colorectal cancer, diverticular disease and inflammatory bowel disease. Dr. Regenbogen is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Ileostomy, and Hernia Surgery. Dr. Regenbogen is board certified in Surgery and Colon & Rectal Surgery.

John C. Byrn, M.D is a Clinical Professor of Surgery in the Division of Colorectal Surgery. He graduated from Hope College with a B.A. in Chemistry and received his MD degree from the University of Illinois-Chicago College of Medicine. He trained in general surgery at Mount Sinai School of Medicine in New York, NY. Dr. Byrn went on for his Colon and Rectal residency at the Cleveland Clinic, Cleveland, OH. Dr. Byrn was a Clinical Assistant and Associate Professor of Surgery at the University of Iowa Hospitals and Clinics from 2009-2015 and served as the Chief of the Section of Colorectal Surgery from 2013-2105. Dr. Byrn is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Rectal Prolapse, Familial Colorectal Cancer, Ileostomy, and Colostomy. Dr. Byrn is board certified in Surgery and Colon & Rectal Surgery.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Dr. Lesly Dossett, MD, MPH, is the Maud T. Lane Research Professor for Cancer Quality Improvement and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett earned her medical degree from Vanderbilt University School of Medicine in 2003, having attended on a United States Navy Health Professions Scholarship. She completed her general surgery residency at Vanderbilt University in 2010, which included a health services research fellowship and completion of an MPH. After residency, Dr. Dossett served on active duty with the United States Navy in several roles stateside and overseas, including completing two deployments supporting combat operations in Afghanistan. After leaving the Navy in 2014, Dr. Dossett completed a clinical fellowship in Complex General Surgical Oncology at Moffitt Cancer Center and joined the faculty of the University of Michigan in 2016.Dr. Dossett specializes in treating patients with melanoma, soft tissue sarcoma, and breast cancer. Her research leverages implementation science frameworks and behavioral strategies to improve healthcare value. As co-director of the Michigan Program for Value Enhancement (MPrOVE), she works to translate value-based research findings into practice at Michigan Medicine and then scale those strategies more broadly to hospitals and healthcare systems. She is a principal investigator for R01s funded by the National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ). She serves as a mentor on several federally funded training grants and career development awards.Dr. Dossett is an active member of several national societies. She serves as an officer in the Association for Academic Surgeons (AAS) and in the executive leadership of the American College of Surgeons (ACS) Cancer Research Program (CRP) and the Surgical Outcomes Club.Clinical Specialization:Dr. Dossett’s clinical focus is on melanoma and non-melanoma skin cancers, sarcoma, and breast cancer. She has expertise in locally and regionally advanced melanoma, breast angiosarcoma, retroperitoneal and pelvic sarcoma, breast conservation therapy, and skin and nipple sparing mastectomy. Dr. Dossett is rated as an Advanced provider by MediFind in the treatment of Eccrine Porocarcinoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Retroperitoneal Liposarcoma, Melanoma, Desmoplastic Small Round Cell Tumor, Mastectomy, and Lymphadenectomy. Dr. Dossett is board certified in Surgery and Complex General Surgical Oncology.